On to Stage #2 in my Special Report: “Profit and Protect–What you need to know about stock market stages for 2021. And to my rules for the sells and hedges in Stage #2 for 2021: When you win, you lose. (I just posted sells for ILMN, CTVA, WST and VMW)
I’m starting up my videos on JubakAM.com again–this time using YouTube as a platform. The eleventh YouTube video “Lessons from the Texas Winter Storm: How to Invest in the Energy Grid” went up today.
As of 3:00 p.m. New York time today, February 3, shares of Vaxart (VXRT) were down 58.50% to $9.69 on news that although its coronavirus vaccine candidate triggered several immune responses, it did not produce the neutralizing antibodies that prevent sa virus from replicating. I will sell shares out of my Volatility Portfolio tomorrow
Ok, I don’t want to see “the next GameStop under every rock.” But Vaxart (VXRT) deserves a look or two. (The stock is a member of my Volatility Portfolio where it’s up 5.27 as of the close on February 1 since I added it to the portfolio on July 22, 2020. I also own shares in my personal portfolio.) Here’s what I see with the shares of this company that is in clinical trials of a vaccine for the coronavirus. Vaxart’s vaccine is a pill and it’s the only vaccine pill under development. Shares of Vaxart are up (as of the February 1 close) 54.93% in the last week and 172.68% in the last month. They’ve added 216.46% in the last 3 months and are up 172.68% for 2021 to date as of the close on February 1. The shares moved up another 29.97% today to $15.57 a share.
I see all the signs of a market that’s moved beyond enthusiasm to excess. This stage in a market is called many things. A market melt. Forming a top. You get the idea. We won’t, of course, know if the current levels constitute a top until we get a sustained downturn. And waiting for that confirming downturn can take a while and be very painful if you’ve tried to time the turn with shorts or Put Options and turn out to have been early. The topping process can go on for a while.
Shares of what was once Kensington Capital Acquisition (KCAC) and is now QuantumScape (QS) are up 203.3.7% since I bought Kensington back on October 13, 2020 in my Volatility Portfolio. But Quantumscape isn’t planning to have its solid state lithium ion battery in production until 2024. And most investors don’t understand the wave of dilution that’s about to hit the now public shares of QuantumScape. So I’ll be taking my profits tomorrow.
If you bought shares of Kensington Capital Acquisition (KCAC) along with me on October 13, you’re received a solicitation for a proxy vote to approve the reverse merger of Kensington with privately held QuantumScape, a startup solid state lithium battery company. The merger wis a way for Quantumscape to go public. (Kensington was the 14th and last pick in my Special Report: 10 Stocks for the Post-Coronavirus economy. Kensington has called a special meeting for shareholders for November 25 to approve the merger. You can vote online to 11:59 p.m. tonight. I plan to vote in favor of the merger, since that’s the whole reason for owning shares of Kensington.
